Mise à jour d'une déclaration précédente
No de la demande: 2010-1615
Numéro de référence du titulaire d'homologation: 01-10-22202503
Nom du titulaire (nom légal complet, aucune abbréviation): Wellmark International
Adresse: 100 Stone Road West, Suite 111
Ville: Guelph
État: ON
Pays: Canada
Code postal /Zip: N1G 5L3
Incident chez l'humain
Pays: CANADA
État: BRITISH COLUMBIA
ARLA No d'homologation 25739 ARLA No de la demande d'homologation EPA No d'homologation. 2724-401
Nom du produit: Vet Kem Siphotrol Plus Pump Spray for Homes
Oui
Inconnu
Site: Res. - In Home / Rés. - à l'int. maison
Non
Autre
Sexe: Homme
Âge: >64 yrs / > 64 ans
Système
Persisted until death
Oui
Oui
18
Day(s) / Jour(s)
Non professionnel
Contact avec la zone traitée
Quelle était l'activité? re-entry
Aucun
Peau
Respiratoire
>24 hrs <=3 days / >24 h <=3 jours
>24 hrs <=3 days / >24 h <=3 jours
The product was applied to the perimeter of the room and between the mattresses on March 20th or 21st. The caller's father said he could taste the product after application. He slept on the treated bed overnight. On March 23rd, the elderly man was hospitalized. He has a history of diabetes and chronic obstructive pulmonary disease. The man was on 4 different antibiotics and other medications. The caller's father died on April 9th.
Mort
Product identification was not verified.The caller stated she "did not have the product with her but she thinks this is the product". Inappropriate use of product:Mattresses are not a labeled use site for this product.Caller stated her father slept in the bed the night of the application contrary to her instructions to him.Caller further stated her father partially closed the window after application.No additional information was provided regarding treatment of the premises to determine whether there was compliance with label directions as they relate to the re-entry time frame or proper ventilation of treated area after application.The Prosar specialist told the caller that it was not believed that the product is the cause of the father's symptoms.Once the product is dry it is safe.Adverse health effects from contact with the wet product are typically limited to the upper respiratory tract and resolve without affecting other body functions.Typically once the patient is removed from the source of the vapors and placed into an area with fresh air, those symptoms would resolve.The severity, duration of the symptoms, and the outcome (death) are not consistent with short term (acute) low level exposure to permethrin or S-methoprene. S-Methoprene is essentially non-toxic.Irritation of the skin, eyes and upper respiratory tract are associated with permethrin exposure.Headaches and vomiting as well as asthma-like symptoms have been reported in sensitive individuals.Symptoms are short lived once the source is removed.The (age) year old male was not in good health and had been previously diagnosed with chronic obstructive pulmonary disease.The scarring of the lung tissue, muscle paralysis and onset of pneumonia reported in this case are not symptoms associated with acute low level exposure to permethrin.Permethrin has low vapor pressure and inhalation exposure would not be expected unless there was direct contact with product during application.
Personne affectée
Sexe: Femme
Âge: >19 <=64 yrs / >19 <=64 ans
Système
>1 wk <=1 mo / > 1 sem < = 1 mois
Oui
Non
Non professionnel
Application
Aucun
Peau
Respiratoire
Unknown / Inconnu
Unknown / Inconnu
Caller had opened the windows in the room and sprayed the product on March 20th or 21st. There were no symptoms while spraying the product. The caller has a history of asthma and treatment/medication for blood pressure problems. The caller uses medications: Advair 250, Ventolin rescue inhaler, and Benicar blood pressure medication. The caller was taking antibiotics Biaxion and Cipro for her illnesses.
Modérée
Product identification was not verified.The caller stated she "did not have the product with her but she thinks this is the product".Inappropriate use of product: Mattresses are not a labeled use site for this product.Caller further stated her father partially closed the window after application.No additional information was provided regarding treatment of the premises to determine whether there was compliance with label directions as they relate to the re-entry time frame or proper ventilation of treated area after application.The Prosar specialist told the caller that if the product was wet and inhaled, it could cause upper respiratory irritation and symptoms such as coughing might occur.Once the product was dry, we would not anticipate anything else to occur.Patients who smoke or have underlying respiratory conditions may experience more pronounced symptoms that require medical attention.Inhalers or nebulizer therapy indicated for acute respiratory symptoms may be used in the prescribed manner as symptoms dictate.Symptoms should resolve when area is ventilated and spray has dried.